Marksans Pharma Board Approves Unaudited Financial Results for Q3 2026
Marksans Pharma’s board has approved the unaudited standalone and consolidated financial results for the quarter ended December 31, 2025…
PVR INOX Board Approves Q3 2026 Unaudited Financial Results
The Board of Directors of PVR INOX has approved the unaudited standalone and consolidated financial results for the third quarter and nine…
Voltamp Q3 Results – Profit Declines Despite Revenue Growth
Voltamp Transformers Limited announced its Q3 results, reporting a revenue increase to ₹65.65 crore. However, profit after tax decreased to…
Power Finance Corporation Declares Interim Dividend, Approves Financial Results
Power Finance Corporation (PFC) has announced the approval of its financial results for the quarter and nine months ending December 31, 2025.…
Jubilant Ingrevia Q3 FY26 Results Show Resilience Amidst Pricing Pressures
Jubilant Ingrevia announced its Q3 FY26 results, showcasing stable performance with ₹1,051 crore in revenue. Despite pricing challenges,…
Max Healthcare Board Approves Expansion and Financial Results
Max Healthcare Institute Limited’s board approved the Q3 FY26 financial results and an amendment to their services agreement. This…
PVR INOX Board Approves Q3 2026 Financial Results
PVR INOX’s Board of Directors has approved the unaudited standalone and consolidated financial results for Q3 2026 (October-December).…
Jubilant Ingrevia Q3 FY26 Results Show Resilience Amid Pricing Pressures
Jubilant Ingrevia reported its Q3 FY26 results, demonstrating resilience amidst persistent pricing pressures. The company sustained its EBITDA…
Marksans Pharma Q3 Results and Auditor Update
Marksans Pharma has announced its Q3 results, with the Board of Directors approving the unaudited financial results for the quarter and nine…
NAVA Limited Board Approves Unaudited Financial Results for Q3 2026
NAVA Limited’s Board of Directors has approved the unaudited financial results for Q3 2026, ending December 31, 2025. The consolidated…